Carmine Therapeutics is a biotechnology company pioneering a novel class of non-viral gene therapies using red blood cell extracellular vesicles (RCEVs) combined with proprietary payloads. Our mission is to revolutionize the treatment of genetic diseases through innovative, safe, and effective thera...See more
Headquarters:
United States of America
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2019 (7 years)
Address:
700 MAIN ST; LABCENTRAL; CAMBRIDGE, MASSACHUSETTS 02139, US
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
LOW
spending power
